'Indian pharma industry capable of discovering new drugs'

Last Updated: Saturday, August 29, 2015, 20:22

Indian pharma industry is capable of discovering at least a couple of new drugs in the next 10 years, Sun Pharmaceutical Industries founder and managing director Dilip Shanghvi said today

'Pharma exports may have grown 2.2% to $15.2 bn in FY15'

Last Updated: Monday, May 11, 2015, 18:51

Indian pharma exports are estimated to have grown, but at a slower pace of 2.2 percent to about USD 15.2 billion during the financial year ended March 2015 against USD 14.9 billion in the previous fiscal, said a top official of Pharmexcil, an export promotion body, Monday.

Kumar calls for policy, regulation shift in Pharma sector

Last Updated: Tuesday, December 23, 2014, 20:57

Calling for a shift in policy and regulation in pharma sector, government Tuesday stressed on the need for pharma industry to make quality medicines available to public at affordable rates.

Sun-Ranbaxy deal gets FIPB nod

Last Updated: Monday, December 1, 2014, 18:39

The Sun Pharma-Ranbaxy transaction would create the country's largest pharmaceutical company.

Govt retains 100% FDI in existing pharma units

Last Updated: Wednesday, January 8, 2014, 16:18

Government Wednesday decided to retain the policy of allowing 100 percent foreign investment in the existing pharma firms, brushing aside concerns about non- availability of affordable drugs in view of MNCs takeovers.

Hiring grows by 24% in recession-proof pharma sector

Last Updated: Sunday, October 27, 2013, 10:57

Amid continuing business expansion, hiring in India's pharmaceutical sector grew an estimated 24 percent in the current financial year and job creation may continue in the near future.

Indian pharma draws more scrutiny as US exports rise

Last Updated: Sunday, September 15, 2013, 08:59

India's drugmakers, battered by a rash of US regulatory rebukes including a record fine for Ranbaxy Laboratories, face closer FDA scrutiny as the agency ramps up its presence in the country.

FDI policy in pharma set for major overhaul

Last Updated: Friday, August 16, 2013, 17:57

The government is set to make major changes in the current FDI policy in the pharmaceuticals sector to protect domestic generic industry in the wake of increasing acquisitions of homegrown companies by foreign players.

US to hike fees for generic drugmakers; Indian firms to be hit

Last Updated: Sunday, August 11, 2013, 12:27

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October.

FIPB likely to defer FDI proposals in pharma sector

Last Updated: Thursday, July 4, 2013, 20:40

The Finance Ministry may defer 10 proposals for FDI in pharmaceutical sector that are listed to be taken up at the FIPB meeting Friday, as the government is yet to review foreign investment policy in existing Indian drug companies.

New pricing norms may hit pharma cos' near-term earnings: ICRA

Last Updated: Thursday, May 30, 2013, 19:12

The proposed market-based pricing mechanism for the pharmaceutical industry is expected to impact near term earnings of companies with relatively higher dependence on Indian market, rating agency ICRA said Thursday.

Outlook for pharma companies positive: ICRA

Last Updated: Thursday, April 11, 2013, 17:41

Painting a favourable picture for the domestic pharmaceutical companies, ICRA said balance sheets of major pharmaceutical companies remain strong and provide adequate room for fund raising if required.